MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the ...

Use of NSAIDs is not associated with an increased risk for disease-related hospitalization in ulcerative colitis, although a small increase is observed in Crohn’s disease.

At least 2.4 million Americans have IBD. So why is it still so hard for women to get an accurate diagnosis?

GLP-1 medications like Ozempic and Wegovy are popular. Learn about the safety, potential benefits, and GI risks of taking ...

The combination of impaired epithelial barrier function, mucosal inflammation and elevated oxidative stress is determinant for the pathogenesis of ulcerative colitis (UC). NF-E2-related factor 2 (NRF2 ...

Though it may seem daunting to make the dietary changes necessary after an IBD diagnosis, these expert ideas will make it ...

ABIVAX Société Anonyme (NASDAQ: ABVX) is one of the best up and coming stocks with highest upside potential. On March 23, ...

Smoking is bad. We know this. But... there's one disease that seems to like it. As in, smokers are way less likely to get it.

Managing ulcerative colitis often involves medications that affect your immune system. Learn which vaccines are recommended ...

Early infliximab use in acute severe ulcerative colitis reduces hospital stay without increasing complications, new study ...

Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will present its abstract evaluating the impact of ...

Recognizes the potential of MH002 to address a serious medical condition with high unmet need Enables accelerated development and increased FDA interactions to streamline review process ...